Omkar Speciality Chemicals Limited has informed the Exchange about General Updates
Awaiting price reaction for this filing.
Omkar Speciality Chemicals has submitted a Broad Step Plan under its approved Resolution Plan. The company, admitted into CIRP in December 2022, received NCLT approval on July 31, 2025 for capital reduction. The entire existing share capital will be reduced to NIL, and fresh equity shares of INR 10 face value will be issued to the Resolution Applicant (RA). After the share allotment, the RA will hold 100% of the company's paid-up capital. To comply with SEBI's Minimum Public Shareholding (MPS) requirement, the company will conduct an Offer for Sale (OFS) of 5% equity shares through the stock exchange mechanism.
Existing shareholders face complete dilution as the Resolution Applicant takes 100% ownership. The company will seek in-principle approval from exchanges before allotting shares to the RA, with MPS compliance following via OFS.